[1]
DOGU, M.H. et al. 2023. GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS: Gilteritinib (XOSPATA ®) in Turkey. Mediterranean Journal of Hematology and Infectious Diseases. 15, 1 (Apr. 2023), e2023031. DOI:https://doi.org/10.4084/MJHID.2023.031.